Author

Jackson EA

Cardiology, University of Alabama, Birmingham - Cited by 9,042 - Cardiovascular Prevention - Digital Health - Women's Health - Physical Activity - Nutrition

Biography

Jackson EA working at Doctoral Scholar, University of Birmingham, UK. His research work is on - A Reflective Commentary on the Economics of Climate Change Mitigation.
Title
Cited by
Year
Do wearable activity trackers increase physical activity among cardiac rehabilitation participants? A systematic review and meta-analysis
C Ashur, TM Cascino, C Lewis, W Townsend, A Sen, D Pekmezi, ...Journal of cardiopulmonary rehabilitation and prevention 41 (4), 249-256, 2021202
17
2021
Lipoprotein (a) and the risk for coronary heart disease and ischemic stroke events among black and white adults with cardiovascular disease
LD Colantonio, V Bittner, MM Safford, S Marcovina, TM Brown, ...Journal of the American Heart Association 11 (11), e025397, 2022202
10
2022
Cost conversations about anticoagulation between patients with atrial fibrillation and their clinicians: a secondary analysis of a randomized clinical trial
CC Kamath, R Giblon, M Kunneman, AI Lee, ME Branda, IG Hargraves, ...JAMA Network Open 4 (7), e211600-e211600, 2021202
9
2021
Impact of a pilot structured mobile technology based lifestyle intervention for patients with nonalcoholic fatty liver disease
MA Tincopa, A Lyden, J Wong, EA Jackson, C Richardson, AS LokDigestive Diseases and Sciences 67 (2), 41-491, 2022202
8
2022
Effect of shared decision‐making for stroke prevention on treatment adherence and safety outcomes in patients with atrial fibrillation: a randomized clinical trial
PA Noseworthy, ME Branda, M Kunneman, IG Hargraves, AL Sivly, ...Journal of the American Heart Association 11 (2), e023048, 2022202
6
2022
Race/ethnic and sex differences in the initiation of non-statin lipid-lowering medication following myocardial infarction
CL Colvin, B Poudel, AP Bress, CG Derington, JB King, Y Wen, L Chen, ...Journal of Clinical Lipidology 1 (), 66-673, 2021202
5
2021
Risk for recurrent cardiovascular disease events among patients with diabetes and chronic kidney disease
D Hubbard, LD Colantonio, RS Rosenson, TM Brown, EA Jackson, ...Cardiovascular Diabetology 20 (1), 1-9, 2021202
4
2021
Depressive symptoms and incident hospitalization for heart failure: findings from the REGARDS study
Y Khodneva, P Goyal, EB Levitan, EA Jackson, S Oparil, MR Sterling, ...Journal of the American Heart Association 11 (7), e022818, 2022202
3
2022
Factors associated with 10-year declines in physical health and function among women during midlife
DH Solomon, A Colvin, BS Lange-Maia, C Derby, S Dugan, EA Jackson, ...JAMA Network Open 5 (1), e214277-e214277, 2022202
3
2022
Randomized evaluation of decision support interventions for atrial fibrillation: Rationale and design of the RED-AF study
AE Jones, MM McCarty, JP Brito, PA Noseworthy, KL Cavanaugh, ...American heart journal 248, 42-52, 2022202
3
2022
Estimated number and percentage of US adults with atherosclerotic cardiovascular disease recommended add-on lipid-lowering therapy by the 2018 AHA/ACC multi-society cholesterol …
CJ Alanaeme, V Bittner, TM Brown, LD Colantonio, N Dhalwani, J Jones, ...American heart journal plus: cardiology research and practice 21, 100201, 2022202
3
2022
Lipoprotein (a) and the risk for atherosclerotic cardiovascular events among adults with chronic kidney disease and a history of atherosclerotic cardiovascular disease
B Poudel, RS Rosenson, S Kent, V Bittner, O Gutierrez, AH Anderson, ...Journal of the American College of Cardiology 79 (9_Supplement), 1511-1511, 0
2
2022
2
2021
Preserving independence among under-resourced older adults in the Southeastern United States: existing barriers and potential strategies for research
EM Enogela, T Buchanan, CS Carter, R Elk, SB Gazaway, BR Goodin, ...International Journal for Equity in Health 1 (1), 1-15, 0
2
2022
Lipid-lowering therapy use and intensification among United States veterans following myocardial infarction or coronary revascularization between 2015 and 2019
Lipid-lowering therapy use and intensification among United States veterans following myocardial infarction or coronary revascularization between 015 and 019AR Zheutlin, CG Derington, JS Herrick, RS Rosenson, B Poudel, ...Circulation: Cardiovascular Quality and Outcomes 15 (1), e008861, 0
2
2022
Patient Awareness of Their Heart Failure Diagnosis and Its Implications for Epidemiologic Studies and Clinical Care
P Goyal, A Zhu, SA Clarkson, TM Brown, R Durant, JR Kingery, MJ Shen, ...American Journal of Cardiology 95, 27-30, 2023202
1
2023
What is the association of renin–angiotensin–aldosterone system inhibitors with COVID-19 outcomes: retrospective study of racially diverse patients?
What is the association of renin–angiotensin–aldosterone system inhibitors with COVID-9 outcomes: retrospective study of racially diverse patients?Y Khodneva, G Malla, S Clarkson, R Fu, MM Safford, P Goyal, S Oparil, ...BMJ open 2 (4), e05396, 2022202
1
2022
Association of Perceived Stress With Incident Heart Failure
L Balkan, JB Ringel, EB Levitan, YA Khodneva, LC Pinheiro, MR Sterling, ...Journal of Cardiac Failure 28 (9), 40-40, 2022202
1
2022
Enrolling people of color to evaluate a practice intervention: lessons from the shared decision-making for atrial fibrillation (SDM4AFib) trial
A Sivly, HS Gorr, D Gravholt, ME Branda, M Linzer, P Noseworthy, ...BMC Health Services Research 22 (), -8, 2022202
1
2022
Palpitations across the menopause transition in SWAN: trajectories, characteristics, and associations with subclinical cardiovascular disease
JS Carpenter, YI Cortés, JE Tisdale, Y Sheng, EA Jackson, ...Menopause 30 (), 8-27, 2023202
1
2023